Evidence map›Paper›PMID 36322655›Full record

ArticleScience advances2022

Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility.

Carolina Villarroya-Beltri, Ana Osorio, Raúl Torres-Ruiz, David Gómez-Sánchez, Marianna Trakala, Agustin Sánchez-Belmonte, Fátima Mercadillo, Begoña Hurtado, Borja Pitarch, Almudena Hernández-Núñez and 6 more

Abstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. RecessiveDiagnostics (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Carolina Villarroya-BeltriCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid E-28029, Spain.ORCID 0000-0003-2284-4020
Ana OsorioFamilial Cancer Clinical Unit, CNIO, Madrid E-28029, Spain.ORCID 0000-0001-8124-3984
Raúl Torres-RuizCytogenetic Unit, CNIO, Madrid E-28029, Spain.ORCID 0000-0001-9606-0398
David Gómez-SánchezHereditary Cancer Laboratory, Doce de Octubre University Hospital, i+12 Research Institute, Madrid, Spain.ORCID 0000-0002-5170-1590
Marianna TrakalaKoch Institute, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Agustin Sánchez-BelmonteCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid E-28029, Spain.ORCID 0000-0001-6936-1873
Fátima MercadilloFamilial Cancer Clinical Unit, CNIO, Madrid E-28029, Spain.
Begoña HurtadoCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid E-28029, Spain.ORCID 0000-0002-8232-3238
Borja PitarchCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid E-28029, Spain.
Almudena Hernández-NúñezDermatology Service, Fuenlabrada University Hospital, Fuenlabrada, Madrid, Spain.ORCID 0000-0002-9610-8328
Antonio Gómez-CaturlaDigestive Department, University Hospital of Guadalajara, Guadalajara, Spain.ORCID 0000-0003-0987-1809
Daniel RuedaHereditary Cancer Laboratory, Doce de Octubre University Hospital, i+12 Research Institute, Madrid, Spain.ORCID 0000-0002-5377-8890
José PereaMolecular Medicine Unit, Department of Medicine, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.ORCID 0000-0001-5522-8844
Sandra Rodríguez-PeralesCytogenetic Unit, CNIO, Madrid E-28029, Spain.ORCID 0000-0001-7221-3636
Marcos MalumbresCell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid E-28029, Spain.ORCID 0000-0002-0829-6315
Miguel UriosteFamilial Cancer Clinical Unit, CNIO, Madrid E-28029, Spain.ORCID 0000-0001-7583-7305

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Germline mutations leading to aneuploidy are rare, and their tumor-promoting properties are mostly unknown at the molecular level. We report here novel germline biallelic mutations in

Identifiers

PMID36322655
PMCPMC9629740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.